Citadel Advisors’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.39M | Sell |
635,922
-1,839,927
| -74% | -$17.5M | ﹤0.01% | 4230 |
|
|
2025
Q4 | $30.1M | Sell |
2,475,849
-3,227,932
| -57% | -$39.2M | 0.02% | 1902 |
|
|
2025
Q3 | $66.7M | Buy |
5,703,781
+817,767
| +17% | +$9.78M | 0.05% | 1126 |
|
|
2025
Q2 | $45.3M | Buy |
4,886,014
+74,906
| +2% | +$586K | 0.04% | 1310 |
|
|
2025
Q1 | $35.3M | Buy |
4,811,108
+354,298
| +8% | +$2.72M | 0.03% | 1446 |
|
|
2024
Q4 | $38.1M | Buy |
4,456,810
+196,972
| +5% | +$1.92M | 0.04% | 1523 |
|
|
2024
Q3 | $37.1M | Buy |
4,259,838
+205,976
| +5% | +$1.7M | 0.04% | 1494 |
|
|
2024
Q2 | $27.7M | Sell |
4,053,862
-1,366,739
| -25% | -$8.44M | 0.03% | 1676 |
|
|
2024
Q1 | $48.4M | Buy |
5,420,601
+1,884,592
| +53% | +$13.4M | 0.05% | 1239 |
|
|
2023
Q4 | $15.8M | Buy |
3,536,009
+2,246,653
| +174% | +$6.64M | 0.02% | 2273 |
|
|
2023
Q3 | $4.05M | Buy |
1,289,356
+39,605
| +3% | +$162K | ﹤0.01% | 3992 |
|
|
2023
Q2 | $6.45M | Sell |
1,249,751
-276,521
| -18% | -$1.64M | 0.01% | 3269 |
|
|
2023
Q1 | $8.04M | Sell |
1,526,272
-421,464
| -22% | -$2M | 0.01% | 3099 |
|
|
2022
Q4 | $5.47M | Buy |
1,947,736
+555,311
| +40% | +$1.84M | 0.01% | 3705 |
|
|
2022
Q3 | $5.78M | Sell |
1,392,425
-331,568
| -19% | -$1.67M | 0.01% | 3634 |
|
|
2022
Q2 | $6.93M | Buy |
1,723,993
+31,657
| +2% | +$120K | 0.01% | 3218 |
|
|
2022
Q1 | $8.38M | Buy |
1,692,336
+161,314
| +11% | +$894K | 0.01% | 3248 |
|
|
2021
Q4 | $10.7M | Buy |
1,531,022
+1,487,417
| +3,411% | +$11.6M | 0.01% | 2971 |
|
|
2021
Q3 | $436K | Sell |
43,605
-108,645
| -71% | -$1.22M | ﹤0.01% | 10215 |
|
|
2021
Q2 | $2.16M | Buy |
152,250
+44,169
| +41% | +$671K | ﹤0.01% | 6406 |
|
|
2021
Q1 | $1.77M | Sell |
108,081
-1,480,793
| -93% | -$28.5M | ﹤0.01% | 6694 |
|
|
2020
Q4 | $32.9M | Sell |
1,588,874
-33,089
| -2% | -$491K | 0.04% | 1305 |
|
|
2020
Q3 | $12.3M | Buy |
1,621,963
+1,401,694
| +636% | +$11.6M | 0.02% | 2039 |
|
|
2020
Q2 | $1.83M | Buy |
220,269
+161,032
| +272% | +$1.07M | ﹤0.01% | 4736 |
|
|
2020
Q1 | $294K | Buy |
59,237
+27,410
| +86% | +$135K | ﹤0.01% | 7374 |
|
|
2019
Q4 | $126K | Buy |
31,827
+13,573
| +74% | +$47.2K | ﹤0.01% | 8450 |
|
|
2019
Q3 | $55K | Sell |
18,254
-1,966
| -10% | -$8.79K | ﹤0.01% | 8676 |
|
|
2019
Q2 | $89K | Sell |
20,220
-5,884
| -23% | -$21.8K | ﹤0.01% | 8573 |
|
|
2019
Q1 | $104K | Sell |
26,104
-38,602
| -60% | -$155K | ﹤0.01% | 8542 |
|
|
2018
Q4 | $258K | Buy |
64,706
+39,940
| +161% | +$220K | ﹤0.01% | 7501 |
|
|
2018
Q3 | $170K | Buy |
24,766
+4,330
| +21% | +$27.2K | ﹤0.01% | 8328 |
|
|
2018
Q2 | $138K | Buy |
+20,436
| New | +$140K | ﹤0.01% | 8111 |
|
|
2018
Q1 | – | Sell |
-11,589
| Closed | -$65.2K | – | 8684 |
|
|
2017
Q4 | $52K | Buy |
+11,589
| New | +$59.2K | ﹤0.01% | 7621 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 7956 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 7956 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 7923 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 7748 |
|
|
2016
Q3 | – | Sell |
-57,791
| Closed | -$352K | – | 7696 |
|
|
2016
Q2 | $286K | Buy |
+57,791
| New | +$573K | ﹤0.01% | 5283 |
|
|
2016
Q1 | – | Sell |
-9,542
| Closed | -$72.3K | – | 7651 |
|
|
2015
Q4 | $89K | Buy |
+9,542
| New | +$103K | ﹤0.01% | 6819 |
|
|
2015
Q3 | – | Sell |
-17,682
| Closed | -$372K | – | 9149 |
|
|
2015
Q2 | $372K | Buy |
+17,682
| New | +$438K | ﹤0.01% | 5421 |
|
Other funds holding OCUL
DTC
ACA
SR
VA
VCM
